News Quantified

STIM – neuronetics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Neuronetics Comments on Letter from Pointillist Family Office

Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business [Yahoo! Finance]

Neuronetics Announces Chief Financial Officer Transition [Yahoo! Finance]

Neuronetics Announces Chief Financial Officer Transition

-24.4%

BEAT

38.6%

MISS

9.5%

MISS

-2.0%

MISS

Canaccord Genuity

Form EFFECT Neuronetics, Inc.

Form DEFA14A Neuronetics, Inc.

Form DEF 14A Neuronetics, Inc. For: May 28

Form SCHEDULE 13D/A Neuronetics, Inc. Filed by: Chernett Jorey

Form 8-K Neuronetics, Inc. For: Mar 31

Top News Gainers

4/13 Form 8-K Neuronetics, Inc. For: Apr 08 21.6%

3/30 Neuronetics Recognized as 2020 Top Neurology Device Provider 17.2%

4/9 Neuronetics Inc (NASDAQ: STIM) had its price target lowered by analysts at Canaccord Genuity from $7.00 to $4.00. They now have a "buy" rating on the stock. 12.6%

3/11 Form 4 Neuronetics, Inc. For: Mar 10 Filed by: Furlong Stephen 9.5%

3/3 Form 8-K Neuronetics, Inc. For: Mar 03 7.2%

3/5 Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO 7.1%

9/6 Form 4 Neuronetics, Inc. For: Sep 04 Filed by: Thatcher Christopher 4.8%

2/14 Form SC 13G/A Neuronetics, Inc. Filed by: INTERWEST PARTNERS VIII LP 4.6%

5/13 Form 4 Neuronetics, Inc. For: May 09 Filed by: Donato Peter 4.6%

7/25 Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference 4.6%

Top News Decliners

11/5 Q3/2019 9/30/2019 EPS -0.370 ZacksConsensus -0.410 ActVsEst 0.040 - Beat -39.1%

3/6 Form 8-K Neuronetics, Inc. For: Mar 05 -28.4%

3/6 Neuronetics up 54% premarket on accelerated review status for NeuroStar [Seeking Alpha] -23.2%

3/3 Neuronetics' (STIM) CEO Chris Thatcher on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -17.1%

11/5 Neuronetics Inc (NASDAQ: STIM) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -11.0%

5/28 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Neuronetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm -9.3%

3/16 Form 4 Neuronetics, Inc. For: Mar 12 Filed by: Farley Brian E -9.3%

2/18 Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call -8.7%

5/7 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus -0.370 ActVsEst (0.050) - Miss -7.9%

5/23 Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference -6.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day